Kilitch Drugs (India)
KILITCHNSE

Kilitch Drugs (India)

₹187.826.87 (3.80%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
181.00
Today’s high
188.00
52 week low
117.25
52 week high
219.50
Open price
181.00
Previous close
180.95
Live volume
47,535
Lower circuit
171.91
Upper circuit
189.99

Fundamentals

Market Cap
₹630Cr
ROE
10.79%
P/E Ratio(TTM)
21.57
EPS(TTM)
8.35
P/B Ratio
2.25
Dividend Yield
0.00%
Industry P/E
37.70
Book Value
79.99
Debt to Equity
0.32
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
JUN '26
Revenue (Cr)
₹47.78
-46.96%
Profit (Cr)
₹1.97
-86.76%
0255075100
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
1Y (TTM)+5%
3Y CAGR+20%
Profit growthValue
1Y (TTM)-13%
3Y CAGR+53%

About

Kilitch Drugs (India) Limited is one of the world's leading and fastest-growing pharmaceutical companies, manufacturing and supplying a broad range of formulations globally. The company embraces purpose-driven leadership to create long-term value beyond financial performance, establishing itself as a significant entity in the pharmaceutical industry. It is committed to achieving sustainable healthcare by optimizing its processes and practices through continuous innovation and sustainable operations. Its extensive research has developed a diverse portfolio targeting chronic and acute treatments, including injectables, ophthalmics, effervescent tablets, and nutraceuticals. With a formidable presence across Asia, Africa, CIS, and Latin America, the company offers a broad product portfolio to suit each country's needs. A key international asset is its Ethiopia Unit, the largest Cephalosporin plant in East Africa, producing tablets, capsules, and injectables.;
CEO/MD
Mukund Mehta
Founded in
1992
NSE symbol
KILITCH

Shareholding pattern

Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Shareholder details

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹2,814.00
+3.20 (0.11%)
L
    H
    21,361.1931.515.96
    PfizerPFIZER
    ₹4,596.50
    -13.20 (0.29%)
    L
      H
      21,107.3228.715.02
      ₹6,851.00
      -93.00 (1.34%)
      L
        H
        17,327.00102.1519.85
        Natco PharmaNATCOPHARM
        ₹838.30
        +9.65 (1.16%)
        L
          H
          14,848.2112.971.61
          Livesquawk
          Kilitch Drugs' Q1 revenue rises to ₹449M from ₹431M YoY.
          Livesquawk
          Kilitch Drugs begins nutraceutical production at a new facility in Raigad, Maharashtra.
          Livesquawk
          Kilitch Drugs' Q4 EBITDA rose 51% YoY to ₹221M from ₹146M. EBITDA margin improved to 24.7%, up 0.9pp from 23.8% YoY.
          2026
          13
          Aug
          Quarterly Result
          Release date
          15
          May
          Quarterly & Annual Result
          Release date

          24
          Mar
          Bonus
          Ex date
          1:1
          Ratio

          For every 1 shares you hold, you will receive 1 additional shares
          Bonus ratio1:1
          Ex date24 Mar ‘26
          Record date24 Mar ‘26
          Announcement date18 Mar ‘26

          18
          Mar
          Bonus
          Announced
          1:1
          Ratio

          For every 1 shares you hold, you will receive 1 additional shares
          Bonus ratio1:1
          Ex date24 Mar ‘26
          Record date24 Mar ‘26
          Announcement date18 Mar ‘26
          11
          Feb
          Quarterly Result
          Release date
          2025
          13
          Nov
          Quarterly Result
          Release date
          13
          Aug
          Quarterly Result
          Release date

          15
          Jul
          Rights Entitlement
          Ex date
          2:23
          Ratio

          2 rights eligible for every 23 existing shares held
          Ratio2:23
          Offer price₹357.00
          Ex date15 Jul ‘25
          Record date15 Jul ‘25
          Announcement date9 Jul ‘25

          9
          Jul
          Rights Entitlement
          Announced
          2:23
          Ratio

          2 rights eligible for every 23 existing shares held
          Ratio2:23
          Offer price₹357.00
          Ex date15 Jul ‘25
          Record date15 Jul ‘25
          Announcement date9 Jul ‘25
          Events calendar
          View upcoming events in other stocks